MEDICAL FOOD OR NUTRITIONAL SUPPLEMENT FOR MANAGING BLOOD GLUCOSE LEVELS AND METHOD OF MANUFACTURING SAME

• US 20120093940A1
• Filed: 04/11/2011
• Published: 04/19/2012
• Est. Priority Date: 08/22/2007
• Status: Active Grant

• Current Assignee: Response Scientific, Inc.
• Original Assignee: Response Scientific, Inc.
• Inventors: Opara, Emmanuel C., Webster, Gregory D.
• Granted Patent: US 8,420,125 B2
• Time in Patent Office: Days
• US Class Current: 424/502
• CPC Class Codes: A61K 31/381 having five-membered rings
• CPC Class Codes: A61K 31/51 Thiamines, e.g. vitamin B1
• CPC Class Codes: A61P 3/08 for glucose homeostasis pancreatic hormones A61P5/48
• CPC Class Codes: A61P 3/10 for hyperglycaemia, e.g. antidiabetics

Abstract

A medical food and/or nutritional supplement for oral administration by mammals includes α-lipoic acid, linolenic acid complex, biotin, and coenzyme Q-10. A preferred method of manufacturing the medical food or nutritional supplement is by separate microencapsulation of one or more of the components followed by encapsulation of the individual components, for oral administration. Other methods of delivery include packaging in impermeable, disposable packets and mixing the formulations with food or a cold liquid.

Claims

1. A method of manufacturing a medical food and/or nutritional supplement for use in managing blood glucose levels, comprising:

microencapsulating at least one of α

-lipoic acid, linolenic acid complex, biotin and coenzyme Q-10, wherein the linolenic acid complex comprises linolenic acid, linoleic acid and γ

-linolenic acid; and

mixing the microencapsulated at least one of α

-lipoic acid, linolenic acid complex, biotin and coenzyme Q-10, with one or more of α

-lipoic acid, linolenic acid complex, biotin and coenzyme Q-10, to form a product for oral administration comprising α

-lipoic acid, linolenic acid complex, biotin and coenzyme Q-10.

2. A medical food and/or nutritional supplement for use in managing blood glucose levels manufactured according to claim 1.

3. The method of manufacturing of claim 1 wherein a daily dosage comprises:

α

-lipoic acid—

50 to 1875 mg.;

linolenic acid complex—

12.5 to 3000 mg.;

biotin—

2.5 to 18.75 mg.; and

coenzyme Q-10—

25 to 375 mg.

4. A medical food and/or nutritional supplement for use in managing blood glucose levels manufactured according to claim 3.